BrightSpring Health Services Inc

BrightSpring insider trades reveal executive confidence: buying deep‑discount shares and selling at market prices after a $20 M offering, highlighting growth potential in specialty pharmacy and diagnostic imaging.

BrightSpring’s $40.96 insider sale of 20 M shares fuels growth plans, tech‑driven home‑care, and investor confidence amid a $819 M secondary offering.